The Food and Drug Administration on Thursday issued an emergency use authorization for what it said is the first device that can detect COVID-19 in breath samples.

The InspectIR COVID-19 Breathalyzer is about the size of a piece of carry-on luggage, the FDA said, and can be used in doctor’s offices, hospitals and mobile testing sites. The test, which can provide results in less than three minutes, must be carried out under the supervision of a licensed health care provider.

Dr. Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, called the device “yet another example of the rapid innovation occurring with diagnostic tests for COVID-19.”

The FDA said the device was 91.2% accurate at identifying positive test samples and 99.3% accurate at identifying negative test samples.

“InspectIR expects to be able to produce approximately 100 instruments per week, which can each be used to evaluate approximately 160 samples per day,” the agency said. “At this level of production, testing capacity using the InspectIR COVID-19 Breathalyzer is expected to increase by approximately 64,000 samples per month.”

Share:
More In Science
Artechouse's Newest Exhibition Uses Latest NASA Images
Artechouse, a digital art studio in New York City, has a new exhibition that lets visitors experience never-before-seen images that the James Webb space telescope captured. Cheddar News takes a peek inside the newest immersive experience.
Report: Shortage of Cancer Drugs
A report said that cancer centers are dealing with shortages of carboplatin and cisplatin, drugs that are used to treat cancers.
Health Expert Offers Tips for Coping with Poor Air Quality
With large swaths of the East Coast blanketed with smog, many are worried about their health. Mangala Narasimhan, director of critical care services at Northwell Health, offers some peace of mind with a handful of expert tips for coping with poor air quality. 
Load More